Brooks Laboratories Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 47,904 shares,. Its Average Traded Price (ATP) is ₹66.50, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹65.07.
Brooks Laboratories has an upper circuit limit of ₹78.08 and a lower circuit limit of ₹52.06. The total value traded stands at ₹31.86 L, and the delivery percentage for the day is 57.4%.
The stock is currently traded with a market lot size of 1. Brooks Laboratories also offers a dividend yield of 0%.
Brooks Laboratories Share Price Chart
Brooks Laboratories Share Key Metrics
Volume
47904.00
Market Cap
191.68 CR
LTQ@LTP
1@65.07
ATP
66.5
Var Margin
50 %
Circuit Range
52.06-78.08
Delivery %
57.4 %
Value
31.86 L
ASM/GSM
No
Market Lot
1
Brooks Laboratories Resistance and Support
Pivot 66.32
Resistance
First Resistance
68.14
Second Resistance
71.22
Third Resistance
73.04
Support
First Support
63.24
Second Support
61.42
Third Support
58.34
Brooks Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Brooks Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-02-13 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Brooks Laboratories News
Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Brooks Laboratories board has approved a Scheme of Arrangement to demerge its manufacturing business into a wholly-owned subsidiary, Abridge Speciality Limited. Shareholders will receive 1 share of Abridge for every 1 share held in Brooks. The demerged division accounted for 96.66% of total turnover in FY26.
Oct 14 2026 18:22:21
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended From Time To Time)
Brooks Laboratories board has approved the demerger of its manufacturing business into its wholly-owned subsidiary, Abridge Speciality Limited. Shareholders will receive 1 equity share of Abridge for every 1 share held in Brooks Laboratories. The manufacturing division contributed Rs.82.87 crore, representing 96.66% of the total turnover in FY26.
Oct 14 2026 17:47:04
Brooks Laboratories Management
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary & Compliance Officer |
| Bhushan Singh Rana | Whole Time Director |
Brooks Laboratories FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BROOKS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC